Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

Published:2021-02-09 Issue:3 Volume:73 Page:530-541
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Brunner Hermine I.¹^ORCID,Ruperto Nicolino²^ORCID,Zuber Zbigniew³,Cuttica Rubén⁴,Keltsev Vladimir⁵,Xavier Ricardo M.⁶,Burgos‐Vargas Ruben⁷,Penades Inmaculada Calvo⁸,Silverman Earl D.⁹,Espada Graciela¹⁰,Zavaler Manuel Ferrandiz¹¹,Kimura Yukiko¹²^ORCID,Duarte Carolina¹³,Job‐Deslandre Chantal¹⁴,Joos Rik¹⁵,Douglass Wendy¹⁶,Wimalasundera Sunethra¹⁶,Bharucha Kamal N.¹⁷,Wells Chris¹⁶,Lovell Daniel J.¹^ORCID,Martini Alberto²,Benedetti Fabrizio¹⁸,

Affiliation:

1. Cincinnati Children’s Hospital Medical Center Cincinnati Ohio

2. Istituto Giannina Gaslini Pediatria II‐Rheumatologia PRINTO Genoa Italy

3. Andrzej Frycz Modrzewski Krakow University Krakow Poland

4. Hospital General de Niños Pedro de Elizalde Buenos Aires Argentina

5. Samara Regional Clinical Hospital Samara Russia

6. Hospital de Clínicas de Porto Alegre Universidade Federal do Rio Grande do Sul Porto Alegre Brazil

7. Hospital General de México and Universidad Nacional Autónoma de México Mexico City Mexico

8. Hospital Universitario y Politécnico La Fe Valencia Spain

9. University of Toronto Toronto Ontario Canada

10. Hospital de Niños Ricardo Gutierrez Buenos Aires Argentina

11. Instituto Nacional de Salud del Niño Lima Peru

12. Joseph M. Sanzari Children’s Hospital and Hackensack Meridian School of Medicine Hackensack New Jersey

13. Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Mexico City Mexico

14. Hôpital Cochin AP‐HP Université Paris‐Descartes Paris France

15. ZNA Jan Palfijn Antwerpen, Antwerp, Belgium, and University Hospital Ghent Belgium

16. Roche Products, Ltd. Welwyn Garden City UK

17. Genentech, Inc. San Francisco California

18. IRCCS Ospedale Pediatrico Bambino Gesù Rome Italy

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41528

Reference35 articles.

1. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001;Petty RE;J Rheumatol,2004

2. Is it time to move to active comparator trials in juvenile idiopathic arthritis?: A review of current study designs

3. Juvenile idiopathic arthritis

4. Final Height, Armspan, Subischial Leg Length and Body Proportions in Juvenile Chronic Arthritis

5. Update on treatment of arthritis in children: new treatments, new goals;Lovell DJ;Bull NYU Hosp Jt Dis,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orthodontic Management of a Patient With Juvenile Idiopathic Arthritis: A Case Report;Cureus;2024-08-15

2. Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study;Annals of the Rheumatic Diseases;2024-06-07

3. Existing and Emerging Targeted Therapies in Juvenile Psoriatic Arthritis: Challenges and Unmet Needs;Pediatric Drugs;2024-02-04

4. Choice and switch of biologic drugs in juvenile idiopathic arthritis;The Turkish Journal of Pediatrics;2023-12-25

5. How should we approach management of childhood onset chronic anterior uveitis refractory to adalimumab?;Expert Review of Clinical Immunology;2023-11-21